The incentives offered by top journals distort science, just as big bonuses distort banking
These journals create a skewed incentive scheme to support flashy scientists and bogus science. This is the right business model for popular celebrity magazines, but those magazines don’t have the same consequence for medicine, policy and research. The damage that bad publications have on our fields can mean ten years of fruitless research for a field, it means cures being neglected in favor of shams, truth in favor of commercialism. Arguing that the market can sort out these problems by itself won’t work any better for private science journals than it has for private banks.
Original article from Randy Shekman (The Guardian)